Combined Assessment of Serum Alpha-Synuclein and Rab35 is a Better Biomarker for Parkinson's Disease

BACKGROUND AND PURPOSE: It is essential to develop a reliable predictive serum biomarker for Parkinson's disease (PD). The accumulation of alpha-synuclein (αSyn) and up-regulated expression of Rab35 participate in the etiology of PD. The purpose of this investigation was to determine whether th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hung-Li, Lu, Chin-Song, Yeh, Tu-Hsueh, Shen, Yu-Ming, Weng, Yi-Hsin, Huang, Ying-Zu, Chen, Rou-Shayn, Liu, Yu-Chuan, Cheng, Yi-Chuan, Chang, Hsiu-Chen, Chen, Ying-Ling, Chen, Yu-Jie, Lin, Yan-Wei, Hsu, Chia-Chen, Lin, Huang-Li, Chiu, Chi-Han, Chiu, Ching-Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785464/
https://www.ncbi.nlm.nih.gov/pubmed/31591837
http://dx.doi.org/10.3988/jcn.2019.15.4.488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785464/
https://www.ncbi.nlm.nih.gov/pubmed/31591837
http://dx.doi.org/10.3988/jcn.2019.15.4.488

Ejemplares similares